Cargando…
Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling
Phospholipase C δ1 (PLCD1) encodes an enzyme involved in energy metabolism, calcium homeostasis and intracellular movement. It is located at 3p22 in a region that is frequently deleted in multiple cancers, and the PLCD1 enzyme is a potential tumour suppressor in breast cancer that inhibits matrix me...
Autores principales: | Shao, Qing, Luo, Xinrong, Yang, Dejuan, Wang, Can, Cheng, Qiao, Xiang, Tingxiu, Ren, Guosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438712/ https://www.ncbi.nlm.nih.gov/pubmed/28423710 http://dx.doi.org/10.18632/oncotarget.16072 |
Ejemplares similares
-
Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation
por: Li, Xia, et al.
Publicado: (2018) -
Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial-mesenchymal transition in lung adenocarcinoma
por: Jian, Yao, et al.
Publicado: (2022) -
DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer
por: Yin, Xuedong, et al.
Publicado: (2013) -
Simultaneous loss of phospholipase Cδ1 and phospholipase Cδ3 causes cardiomyocyte apoptosis and cardiomyopathy
por: Nakamura, Y, et al.
Publicado: (2014) -
The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation
por: Luo, Xinrong, et al.
Publicado: (2017)